Ascendis Pharma AS is a biotechnology business based in the US. Ascendis Pharma AS shares (ASND) are listed on the NASDAQ and all prices are listed in US Dollars. Ascendis Pharma AS employs 639 staff and has a trailing 12-month revenue of around $33.2 million.
How to buy Ascendis Pharma AS stock
- Open a stock trading account. Use our comparison table or choose from our Top Picks.
- Confirm your payment details. Fund your account with a bank transfer, debit card or credit card and take advantage of any signup bonuses.
- Search for the stock by name or ticker symbol – ASND. It's that simple.
- Trade stocks for $0 and no annual fee
- Start trading with a $0 minimum deposit
- Get up to $1,000 when you fund a new account within 30 days
- Trade stocks and ETFs for $0 and no annual fee
- Minimum deposit of $10 required
- FINDER EXCLUSIVE: Get $15 when you sign up and deposit $100
- Get free stock upon signup
- Earn 4% interest on uninvested cash with Robinhood Gold
- Get 1% match on contributions to a Robinhood IRA
Ascendis Pharma AS stock price (NASDAQ: ASND)Use our graph to track the performance of ASND stocks over time.
Ascendis Pharma AS shares at a glance
|Latest market close||$117.74|
|52-week range||$61.58 - $134.53|
|50-day moving average||$119.87|
|200-day moving average||$103.08|
|Wall St. target price||$0.39|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-8.46|
Buy Ascendis Pharma AS stocks from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.
Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.
Is it a good time to buy Ascendis Pharma AS stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Ascendis Pharma AS price performance over time
|1 week (2023-01-27)||-3.89%|
|1 month (2023-01-03)||-2.47%|
|3 months (2022-11-03)||-1.70%|
|6 months (2022-08-03)||32.34%|
|1 year (2022-02-03)||1.64%|
|2 years (2021-02-03)||-21.50%|
|3 years (2020-02-03)||140.05|
|5 years (2018-02-02)||136.47%|
Ascendis Pharma AS financials
|Revenue TTM||$33.2 million|
|Gross profit TTM||$4.3 million|
|Return on assets TTM||-26.58%|
|Return on equity TTM||-66.69%|
|Market capitalisation||$6.8 billion|
TTM: trailing 12 months
Ascendis Pharma AS share dividends
We're not expecting Ascendis Pharma AS to pay a dividend over the next 12 months.
Ascendis Pharma AS share price volatility
Over the last 12 months, Ascendis Pharma AS's shares have ranged in value from as little as $61.579 up to $134.525. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Ascendis Pharma AS's is 0.4754. This would suggest that Ascendis Pharma AS's shares are less volatile than average (for this exchange).
Ascendis Pharma AS overview
Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult hypoparathyroidism; and TransCon CNP for pediatric achondroplasia. In addition, the company develops TransCon toll like receptors 7/8 agonist for intratumoral delivery; and TransCon IL-2 ß/g for systemic delivery. The company was incorporated in 2006 and is headquartered in Hellerup, Denmark. .
Ascendis Pharma AS in the news
What Makes Ascendis Pharma A/S (ASND) an Attractive Investment Choice?
25 Most Powerful Countries in Europe
Ascendis Pharma Provides Update on Vision 3x3 Strategic Roadmap at 41st Annual J.P. Morgan Healthcare Conference
Frequently asked questionsWhat percentage of Ascendis Pharma AS is owned by insiders or institutions?
Currently 0.059% of Ascendis Pharma AS shares are held by insiders and 120.027% by institutions. How many people work for Ascendis Pharma AS?
Latest data suggests 639 work at Ascendis Pharma AS. When does the fiscal year end for Ascendis Pharma AS?
Ascendis Pharma AS's fiscal year ends in December. Where is Ascendis Pharma AS based?
Ascendis Pharma AS's address is: Tuborg Boulevard 12, Hellerup, Denmark, 2900 What is Ascendis Pharma AS's ISIN number?
Ascendis Pharma AS's international securities identification number is: US04351P1012 What is Ascendis Pharma AS's CUSIP number?
Ascendis Pharma AS's Committee on Uniform Securities Identification Procedures number is: 04351P101
More guides on Finder
How to buy Neuraxis (NRXS) stock when it goes public
Everything we know about the Neuraxis IPO, plus information on how to buy in.
How to buy TXO Energy (TXO) stock
Everything we know about the TXO Energy IPO, plus information on how to buy in.
How to buy Brera (BREA) stock
Everything we know about the Brera IPO, plus information on how to buy in.
How to invest in the S&P 500
What you need to know about investing in the leading indicator for the overall US stock market.
How to buy IPO stock
Buying an IPO is as simple as buying any other stock, but not every trading platform offers IPO stocks.
How to buy Novo Integrated Sciences stock
Steps to owning and managing NVOS, with 24-hour and historical pricing before you buy.
How do ETFs work?
Your simple and straightforward guide to ETFs, how they work and the different types available.
What is stock lending?
Find out how stock lending works, the extra income you could potentially earn and the risks you should be aware of. Plus, compare stock trading platforms that offer stock lending.
How to buy SONDORS (SODR) stock when it goes public
Everything we know about the SONDORS IPO, plus information on how to buy in.
How to buy Bullfrog AI Holdings (BFRG) stock when it goes public
Everything we know about the Bullfrog AI Holdings IPO, plus information on how to buy in.
Ask an Expert